ANG Lifesciences

28.42
-0.58
(-2.00%)
ann
Q4 Quarterly Results are out. Check out the updated financials1 day ago
Viewcross
right
Market Cap
37.14 Cr
EPS
-7.65
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
62.75
52 Week Low
21.03
PB Ratio
0.59
Debt to Equity
0.88
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,667.50
#1 4,00,089.11
35.03
#1 49,887.20
12.06
#1 9,648
-18.99
40.71
6,530.00
1,73,350.98
79.22
8,184.00
0.89
1,600
23.05
59.09
1,473.20
1,18,977.83
22.51
26,520.70
14.17
4,155
30.28
46.34
3,135.00
1,06,102.65
54.96
10,785.70
11.59
1,656
10.91
40.96
1,248.30
1,04,165.06
#1 18.43
28,905.40
12.36
5,578
21.14
65.75
2,352.40
97,054.97
50.15
10,615.60
19.57
1,942
-10.91
37.13
926.40
93,217.52
20.02
19,831.50
13.82
3,831
-0.19
61.14
1,954.00
89,208.10
27.27
20,141.50
#1 19.94
1,936
#1 112.49
42.68
1,143.80
66,432.09
19.10
29,559.20
17.55
3,169
-0.50
42.85
31,135.00
66,159.70
46.07
6,097.20
10.80
1,201
27.83
58.62
Forecast
Actual
Growth Rate
Revenue Growth
-36.06 %
Net Income Growth
3,266.67 %
Cash Flow Change
-135.97 %
ROE
4,333.33 %
ROCE
-98.01 %
EBITDA Margin (Avg.)
-32.15 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
32
36
120
90
50
96
74
60
47
49
57
34
19
38
20
33
25
18
Expenses
31
33
90
70
44
83
62
50
44
50
50
32
21
36
20
31
27
18
EBITDA
2
4
30
20
6
13
12
10
3
-1
7
2
-2
2
-0
3
-2
-0
Operating Profit %
5 %
9 %
25 %
22 %
11 %
13 %
16 %
16 %
6 %
-26 %
12 %
5 %
-10 %
4 %
-9 %
7 %
-9 %
-4 %
Depreciation
0
0
1
1
2
3
2
2
2
3
2
2
2
2
2
2
2
1
Interest
1
1
1
2
2
4
3
3
4
2
2
2
3
4
2
2
2
2
Profit Before Tax
1
2
28
17
2
7
7
4
-3
-6
2
-3
-6
-4
-4
-1
-6
-4
Tax
0
1
8
4
1
2
3
2
-1
-1
1
-0
-0
-0
-1
1
-1
-2
Net Profit
0
1
20
13
1
5
4
3
-2
-5
2
-2
-6
-4
-3
-2
-5
-2
EPS in ₹
0.42
2.30
38.66
12.41
1.29
5.16
3.99
2.20
-1.36
-3.63
1.41
-1.74
-4.52
-2.75
-2.35
-1.53
-3.98
-1.56

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
291
278
242
Fixed Assets
93
88
58
Current Assets
193
183
173
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
198
190
184
Total Liabilities
291
278
242
Current Liabilities
166
162
145
Non Current Liabilities
41
29
22
Total Equity
84
86
76
Reserve & Surplus
69
69
59
Share Capital
10
13
13

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
0
0
Investing Activities
-44
-9
20
Operating Activities
25
26
-10
Financing Activities
20
-17
-10

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
71.01 %
71.07 %
71.09 %
71.14 %
71.15 %
71.15 %
71.15 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.94 %
25.53 %
26.62 %
25.87 %
25.66 %
25.76 %
25.56 %
26.13 %
26.23 %
26.09 %
25.29 %
25.62 %
25.48 %
25.45 %
25.92 %
26.11 %
Others
9.05 %
3.40 %
2.29 %
2.99 %
3.20 %
3.09 %
3.30 %
3.27 %
3.16 %
3.31 %
4.11 %
3.78 %
3.92 %
3.95 %
3.48 %
3.29 %
No of Share Holders
0
328
323
2,522
4,259
5,215
6,939
7,163
7,305
7,055
6,918
6,868
6,631
6,468
6,517
6,508

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 1.33 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 31.29 29.64
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 41.14 38.74
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 46.81 44.92
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 55.70 50.90
14 Jul 2022 BONUS Bonus
1:4
13 Jul 2022 145.32 197.70
04 Nov 2021 DIVIDEND Dividend
1.00 /share
02 Nov 2021 374.80 553.56
BONUS Bonus
1:1
22 Sept 2021 258.12 0.00
18 May 2016 CHANGE OF NAME Change Of Name
NA
18 May 2016 0.00 0.00

Announcements

Financial Year Results For The Year Ended 31.03.20254 days ago
Board Meeting Outcome for Outcome Of Board Meeting4 days ago
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2025
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 May 22, 2025
Disclosure Of Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018- Fund Raising By Issuance Of Debt Securities By Large Corporate (LC) Apr 24, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 22, 2025
Closure of Trading WindowApr 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMar 20, 2025
Appointment of Company Secretary and Compliance OfficerMar 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024Feb 14, 2025
Board Meeting Outcome for Board Meeting Outcome For SUBMISSION OF UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024Feb 14, 2025
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Declaring Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31Feb 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Financial Results For Quarter And Half Year Ended 30.09.2024.Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.11.2024Nov 14, 2024
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015Nov 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Scrutinizer Report And Evoting Result For AGM 30.09.2024 Of ANG Lifesciences India LimitedOct 02, 2024
Disclosure under Regulation 30A of LODROct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMOct 01, 2024
Closure of Trading WindowSep 25, 2024
Reg. 34 (1) Annual Report.Sep 07, 2024
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 07, 2024
Book Closure For 18Th Annual General MeetingSep 07, 2024
Notice Of AGM For FY 2023-24Sep 07, 2024
Unaudited Standalone And Consolidated Financial Result For Quarter Ended As At 30.06.2024Aug 14, 2024
Board Meeting Outcome for Outcome Of Board Meeting Dated 14.08.2024Aug 14, 2024
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 14, 2024
Board Meeting Intimation for Notice Of Board Meeting Under Reg. 29Of SEBI (LODR), 2015Aug 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 17, 2024
Closure of Trading WindowJun 29, 2024
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.Jun 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 13, 2024
Announcement under Regulation 30 (LODR)-CessationJun 13, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Financial Result For Quarter And Year Ended As At 31.03.2024May 30, 2024
Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2024
Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 27, 2024
Board Meeting Intimation for Approval Of Audited Financial Standalone And Consolidated Statements For Quarter And Year Ended 31.03.2024.May 24, 2024
Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 13, 2024
Disclosure And Intimation Of Non-Applicability Of SEBI Circular No SEBI/HO/DDHS/Clr/P /2018/744 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entities.Apr 30, 2024
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Apr 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 20, 2024
Compliance Certificate For The Year Ended 31.03.2024Apr 20, 2024
Clarification On Price MovementApr 10, 2024

Technical Indicators

RSI(14)
Neutral
49.26
ATR(14)
Less Volatile
1.26
STOCH(9,6)
Neutral
25.91
STOCH RSI(14)
Neutral
27.73
MACD(12,26)
Bullish
0.00
ADX(14)
Strong Trend
27.30
UO(9)
Bearish
50.91
ROC(12)
Uptrend But Slowing Down
3.46
WillR(14)
Neutral
-68.42